280 related articles for article (PubMed ID: 7800851)
1. In vitro steroidogenic effects of neuropeptide Y (NPY1-36), Y1 and Y2 receptor agonists (Leu31-Pro34 NPY, NPY18-36) and peptide YY (PYY) on rat adrenal capsule/zona glomerulosa.
Bernet F; Maubert E; Bernard J; Montel V; Dupouy JP
Regul Pept; 1994 Aug; 52(3):187-93. PubMed ID: 7800851
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide Y (NPY)- and vasoactive intestinal peptide (VIP)-induced aldosterone secretion by rat capsule/glomerular zone could be mediated by catecholamines via beta 1 adrenergic receptors.
Bernet F; Bernard J; Laborie C; Montel V; Maubert E; Dupouy JP
Neurosci Lett; 1994 Jan; 166(1):109-12. PubMed ID: 8190350
[TBL] [Abstract][Full Text] [Related]
3. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
Widdowson PS; Buckingham R; Williams G
Brain Res; 1997 Dec; 778(1):242-50. PubMed ID: 9462897
[TBL] [Abstract][Full Text] [Related]
4. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem.
Glaum SR; Miller RJ; Rhim H; Maclean D; Georgic LM; MacKenzie RG; Grundemar L
Br J Pharmacol; 1997 Feb; 120(3):481-7. PubMed ID: 9031753
[TBL] [Abstract][Full Text] [Related]
5. [Leu31-Pro34] neuropeptide Y identifies a subtype of 125I-labeled peptide YY binding sites in the rat brain.
Gehlert DR; Gackenheimer SL; Schober DA
Neurochem Int; 1992 Jul; 21(1):45-67. PubMed ID: 1303142
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y modulates the sensitivity of the rat adrenal cortex to stimulation by ACTH.
Hinson JP; Cameron LA; Kapas S
J Endocrinol; 1995 May; 145(2):283-9. PubMed ID: 7616161
[TBL] [Abstract][Full Text] [Related]
7. Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats.
Gué M; Junien JL; Reeve JR; Rivier J; Grandt D; Taché Y
Br J Pharmacol; 1996 May; 118(2):237-42. PubMed ID: 8735621
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y potentiates selectively the N-methyl-D-aspartate response in the rat CA3 dorsal hippocampus. I. Involvement of an atypical neuropeptide Y receptor.
Monnet FP; Fournier A; Debonnel G; de Montigny C
J Pharmacol Exp Ther; 1992 Dec; 263(3):1212-8. PubMed ID: 1469629
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y (NPY) and peptide YY (PYY) effects in the epididymis of the guinea-pig: evidence of a pre-junctional PYY-selective receptor.
Haynes JM; Hill SJ; Selbie LA
Br J Pharmacol; 1997 Dec; 122(7):1530-6. PubMed ID: 9421306
[TBL] [Abstract][Full Text] [Related]
10. Several receptors mediate the antisecretory effect of peptide YY, neuropeptide Y, and pancreatic polypeptide on VIP-induced fluid secretion in the rat jejunum in vivo.
Souli A; Chariot J; Voisin T; Presset O; Tsocas A; Balasubramaniam A; Laburthe M; Rozé C
Peptides; 1997; 18(4):551-7. PubMed ID: 9210175
[TBL] [Abstract][Full Text] [Related]
11. Peptide YY derivatives as selective neuropeptide Y/peptide YY Y1 and Y2 agonists devoided of activity for the Y3 receptor sub-type.
Dumont Y; Cadieux A; Pheng LH; Fournier A; St-Pierre S; Quirion R
Brain Res Mol Brain Res; 1994 Oct; 26(1-2):320-4. PubMed ID: 7854062
[TBL] [Abstract][Full Text] [Related]
12. Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine.
Tschöpl M; Miller RC; Pelton J; Stoclet JC; Bucher B
Br J Pharmacol; 1993 Nov; 110(3):1098-104. PubMed ID: 8298798
[TBL] [Abstract][Full Text] [Related]
13. Discrimination by benextramine between the NPY-Y1 receptor subtypes present in rabbit isolated vas deferens and saphenous vein.
Palea S; Corsi M; Rimland JM; Trist DG
Br J Pharmacol; 1995 May; 115(1):3-10. PubMed ID: 7647980
[TBL] [Abstract][Full Text] [Related]
14. Further investigations on the effects of neuropeptide Y on the secretion and growth of rat adrenal zona glomerulosa.
Mazzocchi G; Malendowicz LK; Macchi C; Gottardo G; Nussdorfer GG
Neuropeptides; 1996 Feb; 30(1):19-27. PubMed ID: 8868295
[TBL] [Abstract][Full Text] [Related]
15. Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system.
Larsen PJ; Sheikh SP; Jakobsen CR; Schwartz TW; Mikkelsen JD
Eur J Neurosci; 1993 Dec; 5(12):1622-37. PubMed ID: 8124516
[TBL] [Abstract][Full Text] [Related]
16. Effects of sodium depletion on the response of rat adrenal zona glomerulosa cells to stimulation by neuropeptides: actions of vasoactive intestinal peptide, enkephalin, substance P, neuropeptide Y and corticotrophin-releasing hormone.
Hinson JP; Kapas S
J Endocrinol; 1995 Aug; 146(2):209-14. PubMed ID: 7561631
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide Y inhibits potassium-stimulated glutamate release through Y2 receptors in rat hippocampal slices in vitro.
Greber S; Schwarzer C; Sperk G
Br J Pharmacol; 1994 Nov; 113(3):737-40. PubMed ID: 7858862
[TBL] [Abstract][Full Text] [Related]
18. Acute action of polypeptide YY (PYY) on rat adrenocortical cells: in vivo versus in vitro effects.
Neri G; Andreis PG; Malendowicz LK; Nussdorfer GG
Neuropeptides; 1991 Jun; 19(2):73-6. PubMed ID: 1658675
[TBL] [Abstract][Full Text] [Related]
19. Actions of neuropeptide Y on the rat adrenal cortex.
Renshaw D; Thomson LM; Carroll M; Kapas S; Hinson JP
Endocrinology; 2000 Jan; 141(1):169-73. PubMed ID: 10614636
[TBL] [Abstract][Full Text] [Related]
20. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC
Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]